When radiopharmaceuticals are used to help diagnose medical problems, only small amounts are given to the patient. The radiopharmaceutical then passes through, or is taken up by, an organ of the body (which organ depends on what radiopharmaceutical is used and how it has been given). Then the radioactivity is detected, and pictures are produced, by special imaging equipment. These pictures allow the nuclear medicine doctor to study how the organ is working and to detect cancer or tumors that may be present in the organ.
Name | Updated |
---|---|
Sulfur hexafluoride (Sulfur hexafluoride [ sul-fur-hex-a-flor-ide ]) | 16-Aug-2023 |
Florbetapir f 18 (Florbetapir f 18 [ flor-bet-a-pir ]) | 15-Aug-2023 |
Ioflupane i-123 (Ioflupane i-123 [ eye-oh-floo-payne ]) | 13-Aug-2023 |
Iobenguane i-123 (Iobenguane i-123 [ eye-oh-ben-gwayne ]) | 11-Aug-2023 |
Amyvid (Florbetapir f 18 [ flor-bet-a-pir ]) | 05-Aug-2023 |
Adreview (Iobenguane i-123 [ eye-oh-ben-gwayne ]) | 05-Aug-2023 |
Vizamyl (Flutemetamol f18 injection) | 14-Jul-2023 |
Posluma (Flotufolastat f 18) | 13-Jul-2023 |
Lumason (Sulfur hexafluoride [ sul-fur-hex-a-flor-ide ]) | 13-Jul-2023 |
Datscan (Ioflupane i-123 [ eye-oh-floo-payne ]) | 13-Jul-2023 |